Fangxia Wang

1.4k total citations
38 papers, 411 citations indexed

About

Fangxia Wang is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Fangxia Wang has authored 38 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 16 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Fangxia Wang's work include Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (8 papers) and CAR-T cell therapy research (7 papers). Fangxia Wang is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Multiple Myeloma Research and Treatments (8 papers) and CAR-T cell therapy research (7 papers). Fangxia Wang collaborates with scholars based in China and United States. Fangxia Wang's co-authors include Yinxia Chen, Wanhong Zhao, Liufang Gu, Xing-Mei Cao, Aili He, Aili He, Bo Lei, Jie Liu, Wanggang Zhang and Ju Bai and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Fangxia Wang

36 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangxia Wang China 9 199 157 151 88 44 38 411
Mala K. Talekar United States 11 203 1.0× 197 1.3× 92 0.6× 63 0.7× 21 0.5× 17 372
Ellen J. B. Derissen Netherlands 7 81 0.4× 237 1.5× 63 0.4× 36 0.4× 20 0.5× 8 356
Janice Brown United States 4 94 0.5× 313 2.0× 127 0.8× 46 0.5× 36 0.8× 5 423
Sanil Bhatia Germany 13 201 1.0× 351 2.2× 93 0.6× 112 1.3× 13 0.3× 40 534
Heike I. Krupka United States 11 212 1.1× 332 2.1× 84 0.6× 41 0.5× 23 0.5× 15 608
Indranil Basu United States 9 158 0.8× 344 2.2× 33 0.2× 70 0.8× 62 1.4× 17 543
Samantha Bruno Italy 13 67 0.3× 228 1.5× 85 0.6× 47 0.5× 15 0.3× 40 417
Carl W. McCrady United States 13 154 0.8× 124 0.8× 50 0.3× 133 1.5× 17 0.4× 21 381
Jais Rose Bjelke Denmark 10 142 0.7× 189 1.2× 56 0.4× 37 0.4× 21 0.5× 18 480
Robyn L. Schenk Australia 9 154 0.8× 277 1.8× 30 0.2× 149 1.7× 11 0.3× 14 495

Countries citing papers authored by Fangxia Wang

Since Specialization
Citations

This map shows the geographic impact of Fangxia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangxia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangxia Wang more than expected).

Fields of papers citing papers by Fangxia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangxia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangxia Wang. The network helps show where Fangxia Wang may publish in the future.

Co-authorship network of co-authors of Fangxia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fangxia Wang. A scholar is included among the top collaborators of Fangxia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangxia Wang. Fangxia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fangxia, et al.. (2025). The Euler-Sombor Index of Trees. match Communications in Mathematical and in Computer Chemistry. 94(3). 739–760.
2.
Zhou, Zhijun, Chenze Zhang, Yuanyuan Guo, et al.. (2025). ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16. Journal of Clinical Investigation. 135(22). 2 indexed citations
3.
Wang, Fangxia, Yongxing Du, Lijuan Wang, et al.. (2025). Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer. Cancer Letters. 614. 217523–217523. 6 indexed citations
5.
Liu, Rui, Rui Yang, Xuezhu Xu, et al.. (2024). Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA‐specific CAR‐T therapy: A retrospective analysis of LEGEND‐2. British Journal of Haematology. 204(5). 1780–1789. 4 indexed citations
6.
Wang, Fangxia, et al.. (2024). Maximum Atom Bond Sum Connectivity Index of Molecular Trees with a Perfect Matching. match Communications in Mathematical and in Computer Chemistry. 92(3). 653–669. 1 indexed citations
7.
9.
Wang, Fangxia, et al.. (2023). On the Maximum Atom-Bond Sum-Connectivity Index of Trees. match Communications in Mathematical and in Computer Chemistry. 91(3). 709–723. 8 indexed citations
10.
Wang, Fangxia, et al.. (2023). The Effect of N and KH2PO4 on Skin Color, Sugars, and Organic Acids of “Flame Seedless” Grape. Agronomy. 13(3). 902–902. 3 indexed citations
11.
Wang, Fangxia & Baoyindureng Wu. (2023). The k-Sombor Index of Trees. Asia Pacific Journal of Operational Research. 41(1). 1 indexed citations
12.
Wang, Fangxia & Baoyindureng Wu. (2022). The Proof of a Conjecture on the Reduced Sombor Index. match Communications in Mathematical and in Computer Chemistry. 88(3). 583–591. 4 indexed citations
13.
Bai, Ju, Jianli Wang, Yun Yang, et al.. (2021). Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia. Journal of Immunotherapy. 44(4). 141–150. 2 indexed citations
14.
Wu, Dong, Peihua Zhang, Ying Shen, et al.. (2020). CD138<sup>-</sup> multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient. Aging. 12(22). 23067–23081. 7 indexed citations
15.
Wang, Baiyan, Jie Liu, Wanhong Zhao, et al.. (2020). Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China. Blood. 136(Supplement 1). 6–6. 16 indexed citations
16.
Chen, Hongli, Fangxia Wang, Pengyu Zhang, et al.. (2019). Management of cytokine release syndrome related to CAR-T cell therapy. Frontiers of Medicine. 13(5). 610–617. 77 indexed citations
17.
Shen, Ying, Aili He, Fangxia Wang, et al.. (2017). Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia. Medicina Clínica. 151(9). 339–344. 2 indexed citations
18.
19.
Gu, Liufang, Fangxia Wang, Xing-Mei Cao, et al.. (2010). Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 137(6). 997–1003. 21 indexed citations
20.
Zhang, Wanggang, Fangxia Wang, Yinxia Chen, et al.. (2007). Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia. American Journal of Hematology. 83(3). 185–188. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026